iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/22547473
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May 1;156(9):635-48.
doi: 10.7326/0003-4819-156-9-201205010-00006.

Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis

Affiliations
Review

Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis

Heidi D Nelson et al. Ann Intern Med. .

Abstract

Background: Identifying risk factors for breast cancer specific to women in their 40s could inform screening decisions.

Purpose: To determine what factors increase risk for breast cancer in women aged 40 to 49 years and the magnitude of risk for each factor.

Data sources: MEDLINE (January 1996 to the second week of November 2011), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (fourth quarter of 2011), Scopus, reference lists of published studies, and the Breast Cancer Surveillance Consortium.

Study selection: English-language studies and systematic reviews of risk factors for breast cancer in women aged 40 to 49 years. Additional inclusion criteria were applied for each risk factor.

Data extraction: Data on participants, study design, analysis, follow-up, and outcomes were abstracted. Study quality was rated by using established criteria, and only studies rated as good or fair were included. Results were summarized by using meta-analysis when sufficient studies were available or from the best evidence based on study quality, size, and applicability when meta-analysis was not possible. Data from the Breast Cancer Surveillance Consortium were analyzed with proportional hazards models by using partly conditional Cox regression. Reference groups for comparisons were set at U.S. population means.

Data synthesis: Sixty-six studies provided data for estimates. Extremely dense breasts on mammography or first-degree relatives with breast cancer were associated with at least a 2-fold increase in risk for breast cancer. Prior breast biopsy, second-degree relatives with breast cancer, or heterogeneously dense breasts were associated with a 1.5- to 2.0-fold increased risk; current use of oral contraceptives, nulliparity, and age 30 years or older at first birth were associated with a 1.0- to 1.5-fold increased risk.

Limitations: Studies varied by measures, reference groups, and adjustment for confounders, which could bias combined estimates. Effects of multiple risk factors were not considered.

Conclusion: Extremely dense breasts and first-degree relatives with breast cancer were each associated with at least a 2-fold increase in risk for breast cancer in women aged 40 to 49 years. Identification of these risk factors may be useful for personalized mammography screening.

Primary funding source: National Cancer Institute.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Literature search and selection
BMI = body mass index; OC = oral contraceptive. *Cochrane databases include the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews. †Other sources include reference lists, Scopus, and studies suggested by experts. ‡Some articles are included for more than 1 risk factor. §No articles met inclusion criteria for race/ethnicity, menopausal stage and type (surgical/nonsurgical), age at menopause, and menopausal hormone use. ||Published meta-analyses. ¶ Although some studies met inclusion criteria for the systematic review, they did provide data for the meta-analysis because they used dissimilar categories or different measures than the other included studies.

Comment in

Similar articles

Cited by

References

    1. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll of Radiol. 2010;7(1):18–27. - PubMed
    1. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;53(3):141–69. - PubMed
    1. American College of Obstetricians and Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol. 2011;118(2 Pt 1):372–82. - PubMed
    1. U S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26. - PubMed
    1. van Ravesteyn N, Miglioretti D, Stout N, Lee S, Schechter C, Buist D, et al. What level of risk tips the balance of benefits and harms to favor screening mammography starting at age 40? Ann of Intern Med. 2011 Submitted. - PMC - PubMed

Publication types